Treatment of snakebite poisoning

Area of Science:

• Toxicology
• Emergency Medicine
• Herpetology

Background:

• Snakebites represent a significant public health concern in the United States, with approximately 8,000 reported incidents annually.
• Pit vipers are the primary cause of venomous snakebites, accounting for 99% of cases.

Purpose of the Study:

• To review the epidemiology, mechanics, prevention, pharmacology, clinical manifestations, and treatment of snakebites.
• To provide essential information for healthcare professionals, particularly pharmacists, on current snakebite management.

Main Methods:

• Review of existing literature on snakebite epidemiology and treatment modalities.
• Analysis of clinical findings, including local and systemic effects of envenomation.
• Evaluation of immediate and medical treatment strategies, including antivenin therapy.

Main Results:

• Envenomation symptoms include pain, edema, ecchymoses, and potential cardiac, hematologic, neurologic, renal, and pulmonary toxicity.
• Local tissue necrosis is a major clinical finding in most snakebite poisonings.
• Antivenin therapy, administered within four hours, is the cornerstone of medical treatment, alongside supportive care.

Conclusions:

• Effective snakebite management requires prompt recognition of symptoms and appropriate medical intervention.
• Antivenin therapy is critical for patients exhibiting signs of envenomation, following hypersensitivity testing.
• Pharmacists play a vital role in educating the public and healthcare providers about snakebite treatment and dispelling myths.